Effect of Stopping Behavioral Interventions on Inappropriate Antibiotic Prescribing

Article

In the 12 months after removing behavioral interventions, inappropriate antibiotic prescribing for acute respiratory infections increased relative to control practices, according to a study published by JAMA.

Inappropriate antibiotic prescribing contributes to antibiotic resistance and leads to adverse events. A randomized trial of three behavioral interventions intended to reduce inappropriate prescribing found that 2 of the 3 interventions were effective. Jason N. Doctor, PhD, of the University of Southern California, Los Angeles, examined the persistence of effects 12 months after stopping the interventions. The researchers randomized 47 primary care practices in Boston and Los Angeles and enrolled 248 clinicians to receive 0, 1, 2, or 3 interventions for 18 months. All clinicians received education on antibiotic prescribing guidelines.

The authors found that during the post-intervention period, the rate of inappropriate antibiotic prescribing decreased in control clinics from 14.2 percent to 11.8 percent, and for the different types of interventions, it increased from 7.4 percent to 8.8 percent for suggested alternatives; increased from 6.1 percent to 10.2 percent for accountable justification; and increased from 4.8 percent to 6.3 percent for peer comparison. During the post-intervention period, peer comparison remained lower than control, whereas accountable justification was not different from control.

Limitations of the study are that it only included volunteering clinicians from selected practices, and the post-intervention follow-up was only 12 months.

"These findings suggest that institutions exploring behavioral interventions to influence clinician decision-making should consider applying them long-term," the authors write.

Source: The JAMA Network Journals

Related Videos
Jill Holdsworth, MS, CIC, FAPIC, CRCST, NREMT, CHL
Jill Holdsworth, MS, CIC, FAPIC, CRCSR, NREMT, CHL, and Katie Belski, BSHCA, CRCST, CHL, CIS
Baby visiting a pediatric facility  (Adobe Stock 448959249 by Rawpixel.com)
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Infection Control Today and Contagion are collaborating for Rare Disease Month.
Related Content